我们进行了一项双盲，多中心研究，比较了美沙美拉明与美沙酮对安慰剂治疗活动性溃疡性结肠炎的疗效。
We performed a double-blind, multicenter study, comparing MMX mesalamine vs placebo for the treatment of active ulcerative colitis.
多年来患者都警告说那些治疗可能会有危险，而且他们会被推荐一些应对策略，其中像适应性过渡，一种仅仅建议患者通过少活动来适应他们所患疾病的策略。
For years, patient groups warned such treatments could be dangerous, instead promoting a strategy known as adaptive pacing - which advises patients to adjust to their illness by simply doing less.
若不经治疗，每位活动性结核患者每年将平均感染10至15人。
Left untreated, each person with active TB disease will infect on average between 10 and 15 people every year.
应用推荐